Economic Analysis For Final Effluent Guidelines And Standards For The Pharmaceutical Industry.
Report analyzes compliance costs and economic impacts resulting from Final Effluent Limitations Guidelines and Standards for the Pharmaceutical Manufacturing Industry Point Source Category, and an air rule requiring Maximum Achievable Control Technology (MACT) to control air emissions. Provides economic effects in terms of annualized compliance costs, facility closures, impacts on firms and new sources, employment and communities, foreign trade, environmental justice, and a final RFA.
|Office of Water|
|Office of Science and Technology|
|Engineering and Analysis Division|